Exacerbation of adjuvant arthritis by adrenalectomy is associated with reduced leukocyte lipocortin 1

Journal of Rheumatology

Volumn 24, Issue 9, 1997, Pages 1758-1764

  Yang, Yuan Hang ^a   Hutchinson, Paul ^a   Leech, Michelle ^a   Morand, Eric F ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Adjuvant arthritis; Adrenalectomy; Glucocorticoid; Leukocyte; Lipocortin 1

Indexed keywords

GLUCOCORTICOID; LIPOCORTIN 1; MONOCLONAL ANTIBODY;

ADJUVANT ARTHRITIS; ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FLOW CYTOMETRY; FLUORESCENCE; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS;

ADRENALECTOMY; ANIMALS; ANNEXIN A1; ARTHRITIS, EXPERIMENTAL; EDEMA; EXTREMITIES; FLOW CYTOMETRY; LEUKOCYTES; LYMPHOCYTE SUBSETS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 1842373866     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
2. Sternberg EM, Chrousos GP, Wilder RL, Gold PW: The stress response and the regulation of inflammatory disease. Ann Intern Med 1992;117:854-66.
3. Munck A, Guyre PM, Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Reviews 1984;5:25-44.
4. Wilder RL, Sternberg EM: Neuroendocrine hormonal features in rheumatoid arthritis and related conditions. Curr Opin Rheumatol 1990;2:436-40.
5. Morand EF, Goulding NJ: Glucocorticoids in rheumatoid arthritis - mediators and mechanisms. Br J Rheumatol 1993;32:816-9.
6. Goulding NJ, Guyre PM: Regulation of inflammation by lipocortin 1. Immunol Today 1992;13:295-7.
7. Flower RJ, Rothwell NJ: Lipocortin-1: Cellular mechanisms and clinical significance. Trends in Pharmacological Sciences 1994;15:71-6.
8. Morand EF, Hutchinson P, Hargreaves A, Goulding NJ, Boyce NW, Holdsworth SR: Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol 1995;76:195-202.
9. Goulding NJ, Godolphin JL, Sharland PR, et al: Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 1990;335:1416-8.
10. Solito E, Raugei G, Melli M, Parente L: Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett 1991;291:238-44.
11. Morand EF, Jefferiss CM, Dixey J, Mitra D, Goulding NJ: Impaired glucocorticoid induction of mononuclear leukocyte lipocortin 1 in rheumatoid arthritis. Arthritis Rheum 1994;37:207-11.
12. Perretti M, Flower RJ: Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 1993;150:992-9.
13. Cirino G, Cicala C, Sorrentino L, et al: Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1. Br J Pharmacol 1993;108:573-4.
14. Perretti M, Ahluwalia A, Harris JG, Goulding NJ, Flower RJ: Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse: A qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol 1993;151:4306-14.
15. Wu C-C, Croxtall JD, Perretti M, et al: Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci USA 1995;92:3473-7.
16. Kim KM, Kim DK, Park YM, Kim CK, Na DS: Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett 1994;343:251-5.
17. Morand EF, Yang YH, Hutchinson P: Evidence for an anti-inflammatory action of lipocortin 1 in experimental arthritis (abstr). Arthritis Rheum 1995;(suppl)38:S373.
18. Goulding NJ, Dixey J, Morand EF, et al: Differential expression of annexins-I, -II, -IV and -VI in synovium. Ann Rheum Dis 1995;54:841-5.
19. Morand EF, Yang YH, Hutchinson P: Reduced synovial expression of lipocortin 1 in adjuvant arthritis (abstr). Arthritis Rheum 1994;(suppl)37:S384.
20. Santos L, Tipping PG: Attenuation of adjuvant arthritis in rats by treatment with oxygen radical scavengers. Immunol Cell Biol 1994;72:406-14.
21. Hall V, Janick-Buckner D, Eichelberger L: Evaluation of whole blood lysing techniques for animal blood samples (abstr). Cytometry 1990;suppl 4:107.
22. Pepinsky RB, Sinclair LK, Dougas I, Liang C-M, Lawton P, Browning JL: Monoclonal antibodies to lipocortin-1 as probes for biological function. FEBS Lett 1990;261:247-52.
23. Vishwanath BS, Frey FI, Bradbury M, Dallman MF, Frey BM: Adrenalectomy decreases lipocortin-1 messenger ribonucleic acid and tissue protein content in rats. Endocrinology 1992;130:585-91.
24. Duncan GS, Peers SH, Carey F, Forder R, Flower RJ: The local anti-inflammatory action of dexamethasone in the rat carrageenin oedema model is reversed by an antiserum to lipocortin 1. Br J Pharmacol 1993;108:62-5.
25. Carey F, Forder R, Edge MD, et al: Lipocortin-1 fragment modifies the pyrogenic actions of cytokines in rats. Am J Physiol 1990;259:R266-9.
26. Taylor AD, Loxley HD, Flower RJ, Buckingham JC: Immunoneutralization of lipocortin 1 reverses the acute inhibitory effects of dexamethasone on the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat in vitro and in vivo. Neuroendocrinology 1995;62:19-31.
27. 2 generation by dexamethasone is mimicked by lipocortin 1 in alveolar macrophages. J Clin Invest 1989;83:1936-40.
28. Sakata T, Iwagami S, Tsuruta Y, Suzuki S, Suzuki R: Study of natural lipocortin 1: A potent mediator for macrophage-mediated immunosuppression in tumor-bearing mice. J Immunol 1993;151:4964-72.
29. Cirino G, Flower RJ: Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro. Prostaglandins 1987;34:59-62.
30. Laue L, Kawai S, Brandon DD, et al: Receptor-mediated effects of glucocorticoids on inflammation: Enhancement of the inflammatory response with a glucocorticoid antagonist. J Steroid Biochem 1988;29:591-8.
31. Flower RJ, Parente L, Persico P, Salmon JA: A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. Br J Pharmacol 1986;87:57-62.
32. Sternberg EM, Hill JM, Chrousos GP, et al: Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374-8.
33. Peers SH, Smillie F, Elderfield AJ, Flower RJ: Glucocorticoid- and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo. Br J Pharmacol 1993;108:66-72.
34. 2 activity in rats. J Clin Invest 1993;92:1974-80.
35. Szabo C, Thiemermann C, Wu C-C, Perretti M, Vane JR: Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 1994;91:271-5.
36. Perretti M, Flower RJ: Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry - modulation by glucocorticoids and inflammation. Br J Pharmacol 1996;118:605-10.
37. Yoshino S, Cleland LG: Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established AA, but not established collagen-induced arthritis in rats. J Exp Med 1992;175:907-15.
38. Taurog JD, Sandberg GP, Mahowald ML: The cellular basis of adjuvant arthritis. Cell Immunol 1983;80:198-204.
39. Santos LL, Morand EF, Hutchinson P, Boyce NW, Holdsworth SR: Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol 1997;107:248-54.
40. Sarlis NJ, Chowdrey HS, Stephanou A, Lightman SL: Activation of the hypothalamo-pituitary-adrenal axis and loss of diurnal rhythmicity during adjuvant induced arthritis in the rat. Endocrinology 1992;130:1775-9.
41. Harbuz MS, Rees RG, Lightman SL: HPA axis responses to acute stress and adrenalectomy during adjuvant-induced arthritis in the rat. Am J Physiol 1993;264:R179-85.
42. Swaijo MA, Seaton BA: Annexin structure and membrane interactions: A molecular perspective. Annu Rev Biophys Struct 1994;23:193-213.
43. Sternberg EM, Hill JM, Chrousos GP, et al: Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374-8.
44. Chikanza IC, Petrou P, Kingsley G, Chrousos GP, Panayi GS: Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1281-8.
45. Hall J, Morand EF, Medbak S, et al: Abnormal hypothalamo-pituitary-adrenal axis function in human rheumatoid arthritis: Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum 1994;37:1132-7.
46. Gudbjornsson BB, Skogseid BK, Oberg K, Wide L, Hallgren R: ACTH secretion but impaired cortisol response in patients with active RA. Effect of glucocorticoids. J Rheumatol 1996;23:596-602.
47. Podgorski MR, Goulding NJ, Hall ND, Flower RJ, Maddison PJ: Autoantibodies to lipocortin 1 are associated with impaired corticosteroid responsiveness in rheumatoid arthritis. J Rheumatol 1992;19:1668-71.
48. Goulding NJ, Jefferiss CM, Pan L, Rigby WF, Guyre PM: Specific binding of lipocortin 1 (annexin 1) to monocytes and neutrophils is decreased in rheumatoid arthritis. Arthritis Rheum 1992;35:1395-7.